Since the Dems won I've been circling the generics. They're way beaten down and I imagine will rally soon. Dr Reddy did a secondary over here to raise funds to buy (I believe) a US generic. So I screened with an emphasis as to a likely takeover target. And I wanted of course the biggest risk reward. If I'm getting bought out I want a POP. I want a stock that has fallen from grace and has a prior higher price channel. I came up with Impax Labs. <IPXL>It's lawsuit after lawsuit with these guys and a huge rainmaker was kept off the market causing the stock to creator... HAYWARD, Calif. -- IMPAX Laboratories, Inc. (OTC: IPXL) today announced that Wyeth (NYSE: WYE), has filed a lawsuit against the Company in the United States District Court for the District of Delaware alleging patent infringement related to IMPAX's filing of an Abbreviated New Drug Application (ANDA) for generic versions of Effexor XR(R) 37.5mg, 75mg and 150mg capsules. IMPAX's submission includes a Paragraph IV certification stating the Company believes its product does not infringe upon Wyeth's listed patents. Wyeth markets Effexor XR for the treatment of depression. According to Wolters Kluwer Health, U.S. sales of Effexor XR Capsules were approximately $2.5 billion in the 12 months ended January 31, 2006. "We intend to vigorously defend our ANDA," commented Barry R. Edwards, IMPAX's chief executive officer. "This suit is par for the course for branded pharmaceutical manufacturers attempting to keep patients from access to less expensive medications, even though their patents aren't applicable or will have expired." Now while this case is making it's way through the court system IPXL has actually had a string of good news to report. Read through the news flow and you will see the launch of two new products and a nice win in the courts against I belive SNY. So it's a gamble but the fact that the bad news is priced in and the good news is what if they won? That's a $2 billion plus drug we're talking about. Isn't that worth a risk? If I'm looking for a sexy way into the US Generic market I buy Impax labs, change the lawyers up and roll the dice! This is a LT call but I say there's a good chance this little generic gets it's act together and doubles in price. Look at the recent chart. I've been watching since $7.00 and change> it really looks good. The 5 day is especially impressive. The volume today is REALLY nice. I called this one into the big account folks- the one I'm afraid to ask how much they bought. It's a thinking man's game and I'm thinking generic play IPXL.